New combo therapy aims to fight relapsed leukemia after transplant
Disease control
Recruiting now
This study tests a combination of interferon-γ and donor immune cells for people whose acute myeloid leukemia or myelodysplastic syndromes have returned after a stem cell transplant. The goal is to see if this treatment can control the disease and improve survival. About 45 adult…
Phase: PHASE2 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated May 17, 2026 02:58 UTC